Status:
UNKNOWN
T-Wave Alternans (TWA) Reproducibility in CAD Patients
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-80 years
Brief Summary
Microvolt T-Wave Alternans (MTWA) is a relatively new non-invasive method for identifying patients at increased risk of sudden death from ventricular arrhythmias. MTWA can be measured during a routine...
Detailed Description
The study will be performed in the Cardiac Rehabilitation Center at Assaf Harofeh Medical Center. Patients with coronary artery disease will be eligible to enroll. Patient will undergo an exercise te...
Eligibility Criteria
Inclusion
- Patients enrolled in the cardiac rehabilitation center program
- Patients with CAD
- Age \>18 and \< 80 YO
- Patients with a pacemaker or defibrillator with normal AV conduction
Exclusion
- Patients with chronic AF
- Patients with multiple APB's or PVC's
- Patients who are unable to increase their heart rate to 115 BPM and don't have a pacemaker.
- Patients who are unable to exercise on a bicycle.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00644345
Start Date
May 1 2008
End Date
May 1 2009
Last Update
March 26 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assaf Harofeh Medical Center
Zrifin, Israel